New P3 Coronavirus laboratory at the San Raffaele Hospital
The project aims to create in the San Raffaele Hospital a maximum security area for in vivo studies of SARS-CoV-2 and other Coronavirus infections, indispensable for understanding in detail how the illness evolves and developing new, specifically active anti-viral therapies to combat it. Thanks to advanced technologies made available also with the help of the Prossimo Mio Foundation, this area is the only one of its kind in Italy and one of the few in Europe.
Professor Guidotti with more than 30 professionals including virologists, immunologists and technicians, together with leading European and American experts, handles experiments on the initial phase of development of new highly effective and specific anti-viral drugs to combat this and other Coronaviruses and studies of a vaccine.
A scholarship for a young researcher
The commitment of the Fondazione Prossimo Mio to work alongside the P3 biosecurity laboratory of the San Raffaele hospital continues. It is the only laboratory in Italy for the in vivo study of highly dangerous viruses such as SARS-CoV-2.
The FPM, in agreement with Professor Luca Guidotti, has financed a scholarship for a young researcher to be involved specifically in studying the efficacy of new classes of antiviruses and vaccines. Experiments are proceeding rapidly and researchers have succeeded in perfecting an innovative experimental model for studying the clinical manifestation of Covid 19. “Studying in a laboratory SARS-CoV-2 and its interaction with the immune system can prepare us for any species transmission of new coronaviruses in the same family, as with the MERS and SARS viruses,” says Professor Guidotti